Cargando…

Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review

Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent and relevant healthcare issues. Direct oral anticoagulants (DOACs) are now the first-choice for anticoagulant treatment of these conditions displaying a better efficacy/safety profile than vitamin-K antagonists, mainly du...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballestri, Stefano, Capitelli, Mariano, Fontana, Maria Cristina, Arioli, Dimitriy, Romagnoli, Elisa, Graziosi, Catia, Lonardo, Amedeo, Marietta, Marco, Dentali, Francesco, Cioni, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467481/ https://www.ncbi.nlm.nih.gov/pubmed/32285340 http://dx.doi.org/10.1007/s12325-020-01307-z

Ejemplares similares

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2022)

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
por: Ballestri, Stefano, et al.
Publicado: (2016)

NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
por: Ballestri, Stefano, et al.
Publicado: (2017)

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
por: Nascimbeni, Fabio, et al.
Publicado: (2018)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
por: Ballestri, Stefano, et al.
Publicado: (2021)

Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test
por: Lonardo, Amedeo, et al.
Publicado: (2016)

Alcohol and Steatosis: The Japanese Paradox
por: Lonardo, A., et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
por: Lonardo, Amedeo
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease: Evolving paradigms
por: Lonardo, Amedeo, et al.
Publicado: (2017)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

Opioid epidemic and liver disease
por: Verna, Elizabeth C., et al.
Publicado: (2019)

Oral Anticoagulation in Patients with Chronic Liver Disease
por: Costache, Raluca S., et al.
Publicado: (2023)

Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders: A Commentary on: Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. A Focus on Early Phase Clinical Drug Development, Second Edition
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates
por: Schaefer, Jordan K., et al.
Publicado: (2023)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

A narrative review of malnutrition in chronic liver disease
por: Shin, Soan, et al.
Publicado: (2021)

Living with liver disease in the era of COVID-19-the impact of the epidemic and the threat to high-risk populations
por: Barve, Pranav, et al.
Publicado: (2022)

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2021)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
por: Gillessen, Anton, et al.
Publicado: (2020)

Pharmacological properties of baicalin on liver diseases: a narrative review
por: Yang, Jin-yu, et al.
Publicado: (2021)

Gastrointestinal and liver disease in patients with schizophrenia: A narrative review
por: Grant, Rebecca K, et al.
Publicado: (2022)

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019)

The imbalance of procoagulant and anticoagulant factors in patients with chronic liver diseases in North India
por: Saxena, Priyanka, et al.
Publicado: (2017)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

A Narrative Review of Postoperative Anticoagulation Therapy for Congenital Cardiac Disease
por: Boucher, Alexander A., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
por: Ahmed, Musaab, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease: a narrative review of genetics
por: Danford, Christopher J., et al.
Publicado: (2018)

Sleep disorder in patients with chronic liver disease: a narrative review
por: Shah, Neeraj Mukesh, et al.
Publicado: (2020)

Oral Health and Liver Disease: Bidirectional Associations—A Narrative Review
por: Åberg, Fredrik, et al.
Publicado: (2022)

Updates on Quantitative MRI of Diffuse Liver Disease: A Narrative Review
por: Zerunian, Marta, et al.
Publicado: (2022)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Prothrombin Complex Concentrate in Liver Transplant Surgery: Correction of Therapeutic Anticoagulation and the Coagulopathy of End-Stage Liver Disease: Case Series
por: Marshall, Scarlett V., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure
por: Valbusa, Filippo, et al.
Publicado: (2016)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Liver injury from direct oral anticoagulants
por: Juneja, Deven, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jpumchdffcrvrcup0j0uuau0j1